Navigation Links
K-V Pharmaceutical Company Announces the Completion of the Sale of Nesher Pharmaceuticals, Inc. its Generic Pharmaceutical Business
Date:8/8/2011

for our current products upon their return to the marketplace, as well as the number of preterm births for which Makena™ may be prescribed and its safety profile and side effects profile and acceptance of the degree of patient access to, and pricing for, Makena™;

(7) the possibility that any period of exclusivity may not be realized, including with respect to Makena™, a designated Orphan Drug;

(8) the satisfaction or waiver of the terms and conditions for the continued ownership of the full U.S. and worldwide rights to Makena™ set forth in the previously disclosed Makena™ acquisition agreement, as amended;

(9) the consent decree between the Company and the FDA and the Company's suspension of the production and shipment and the related nationwide recall affecting all of the other products that it manufactured, as well as the related material adverse effect on its revenue, assets and liquidity and capital resources, as more fully described in Part I, Item -- 1 "Business -- (b)Significant Developments -- Discontinuation of Manufacturing and Distribution; Product Recalls; and the FDA Consent Decree" of the Company's Annual Report on Form 10-K for the fiscal year ended March 31, 2011 ("2011 Form 10-K");

(10) the two agreements between the Company and the Office of Inspector General of the U.S. Department of Health and Human Services ("HHS OIG") pertaining to the exclusion of our former chief executive officer from participation in federal healthcare programs and pertaining to the dissolution of our ETHEX subsidiary, in order to resolve the risk of potential exclusion of our Company, as more fully described in Part I, Item 1 -- "Business -- (b)Significant Developments -- Agreements with HHS OIG" of the Company's 2011 Form 10-K;

(11) the plea agreement between the Company and the U.S. Department of Justice and the Company's obligations therewith, as well as the related m
'/>"/>

SOURCE K-V Pharmaceutical Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... and ,S-HERTOGENBOSCH, The Netherlands ... its subsidiary, HealthLink International received its ISO 13485 certificate ... fulfillment and administrative services for medical device manufacturers throughout ... Explains Rick Hughes , President of HealthLink Europe ... ISO 13485 certified facilities, two in Europe ...
(Date:4/1/2015)...  New York College of Health Professions announces a ... with U.S. Patent #8,996,098 donated by its Chairman under ... surgical instrument that allows surgeons to view and compare ... the traditional format of a slide that is used ... surgery, thus providing the surgeon real time analysis and ...
(Date:4/1/2015)... , April 1, 2015 Morgan & ... against the board of directors of Auspex Pharmaceuticals, Inc. ... possible breaches of fiduciary duty and other violations of ... to Teva Pharmaceuticals Industries Ltd.  The transaction is valued ... shares of Auspex and would like to learn more ...
Breaking Medicine Technology:Ground-Breaking Surgical Instrument Allows Surgeons to obtain Real Time Biopsies 2Ground-Breaking Surgical Instrument Allows Surgeons to obtain Real Time Biopsies 3
... (Amex: NEP ), a,medical device company, announced today ... its OLpur(TM) H2H module and OLpur(TM) MD220 filter,for End ... pleased to have reached this important milestone.,There is a ... over dialysis for the ESRD patient, including,studies supporting a ...
... Expansion Plans for SB-509-701 Phase 2 Clinical Trial for Treatment of ... ... SAN FRANCISCO, June 6 Sangamo BioSciences,Inc. (Nasdaq: SGMO ) announced ... in subjects with moderate to,severe diabetic neuropathy. Additionally, based upon positive initial ...
Cached Medicine Technology:Nephros Completes Pivotal U.S. Clinical Trial for its Hemodiafiltration Products 2Nephros Completes Pivotal U.S. Clinical Trial for its Hemodiafiltration Products 3Sangamo BioSciences Provides Update on Diabetic Neuropathy Clinical Programs 2Sangamo BioSciences Provides Update on Diabetic Neuropathy Clinical Programs 3Sangamo BioSciences Provides Update on Diabetic Neuropathy Clinical Programs 4Sangamo BioSciences Provides Update on Diabetic Neuropathy Clinical Programs 5
(Date:4/1/2015)... New Jersey Governor First Spouse ... Spouses from across the country in sponsoring the ... World Down Syndrome Day(WDSD), to increase awareness of, ... of Down syndrome cognition research. , In addition ... American Samoa, Arizona, California, Colorado, Delaware, Florida, Guam, ...
(Date:4/1/2015)... 2015 BioPlus Specialty Pharmacy ... has released a new app to keep health care ... chronic hepatitis C virus (HCV) infection. This ‘HCV Treatment ... from the American Association for the Study of Liver ... new direct-acting oral medications to treat HCV have been ...
(Date:4/1/2015)... BC (PRWEB) April 01, 2015 Dr ... announced that she is now offering her patients an ... services. Patients can participate in “Beauty Days”, which is ... by Dr Roz Kamani’s Kitsilano Skin Care Clinic. It ... directly tell patients about the latest products and services ...
(Date:4/1/2015)... 01, 2015 South Florida’s newest concept ... of Authority (PCOA) approval from the State of Florida. ... ongoing development of a retirement community that will offer ... and spiritual development. , America’s aging population is experiencing ... housing needs of seniors, according to a recent report ...
(Date:4/1/2015)... (PRWEB) April 01, 2015 Health Advocate™, ... and a subsidiary of West Corporation, today launched its ... http://blog.healthadvocate.com and through the Health Advocate member ... consumers get, and stay, healthy. , “We’re pleased to ... to the public,” said Martin Rosen, Executive Vice President, ...
Breaking Medicine News(10 mins):Health News:Governor First Spouses Join with New Jersey First Lady Mary Pat Christie to Support Advances in Biomedical Research to Treat Down Syndrome Cognitive Impairment 2Health News:BioPlus Specialty Pharmacy Releases ‘HCV Treatment Path’ App for Hepatitis C Providers 2Health News:Dr Roz Kamani Now Offers Patients The Opportunity to Learn About Latest Products and Services 2Health News:Casa Sant’Angelo Receives Approval for New Retirement Living 2Health News:Health Advocate Launches New Health and Wellness Blog 2
... outlined a new path for potential therapies to combat ... new understanding of the bodys earliest immune response in ... their findings, to be published in the May edition ... the first evidence describing how viral agents, such as ...
... web-based solution will improve care and enhance ... efficiencies and revenue at 10 Florida locations, TAMPA, ... seamless integration to enhance patient care delivery and,business office ... has selected Sage Software,s Intergy EHR by,Sage Electronic Health ...
... /PRNewswire-FirstCall/ - Traxxec,Ltd, the UK subsidiary of Columbia ... announces that, in line with the licence agreement ... the Interpack conference,and trade show in Dusseldorf, 24-30 ... be present at this,meeting giving the Traxxec RFID ...
... Innovative Thinking, Powerful Creative Drive Success, NEW ... and brand-development firm and member of the Omnicom ... the Year, Category III by Medical,Advertising News at ... in New York., Distinguished by innovative thinking, ...
... PITTSBURGH, April 29 One of the most ... of workers,compensation insurance driven by claims made against ... contain their workers, compensation,exposure and control costs, the ... and Grochmal has published The 2008 Employers, Guide ...
... are expected to participate in the sixth annual ... Massachusetts and,finishing in White Plains, New York, this ... and awareness for the fatal neuromuscular disorder,amyotrophic lateral ... strong this summer, the Trek is distributing cowbells ...
Cached Medicine News:Health News:Immune system kick-started in moist nasal lining in sinusitis, asthma and colds 2Health News:Immune system kick-started in moist nasal lining in sinusitis, asthma and colds 3Health News:Florida Cardiology Chooses Intergy by Sage to Integrate Practice Management and Electronic Health Records 2Health News:Florida Cardiology Chooses Intergy by Sage to Integrate Practice Management and Electronic Health Records 3Health News:Columbia River Resources Inc subsidiary, Traxxec Ltd, reports coverage of its technology at Interpack 2008 (Pink Sheets OTC - CRVR.pk) 2Health News:Columbia River Resources Inc subsidiary, Traxxec Ltd, reports coverage of its technology at Interpack 2008 (Pink Sheets OTC - CRVR.pk) 3Health News:Flashpoint Medica Named Agency of Year by Medical Advertising News 2Health News:New Workers' Compensation Resource Guide Available For Pennsylvania Employers 2Health News:More Cowbell! To end ALS, Riders of the Tri-State Trek Cycle 270 Miles - Making Noise and Raising Money! 2Health News:More Cowbell! To end ALS, Riders of the Tri-State Trek Cycle 270 Miles - Making Noise and Raising Money! 3
Hardy Micro Dissector, bayonet. Working distance 4 1/4" (120 mm). Angled up, tip width: 2 mm....
Cushing-landolt bi-valve speculum for trans-sphenoidal hypophysectomie....
Cushing pituitary scoop, malleable, silver-plated....
... Implant system. Material that has a modulus ... The result is an implant that meets ... while optimizing the fusion environment through an ... design with 5 and 10 degrees of ...
Medicine Products: